There is growing evidence for the vascular contribution to cognitive impairment and dementia in Alzheimer’s disease (AD) and other neurodegenerative diseases. While perfusion deficits have been observed in patients with Alzheimer’s disease and tauopaties, little is known about the role of tau in vascular dysfunction. In the present study, regional cerebral blood (rCBF) was characterized in P301L mice with arterial spin labeling. No differences in rCBF in P301L mice compared to their age-matched non-transgenic littermates at mid (10–12 months of age) and advanced (19–21 months of age) disease stages. This was concomitant with preservation of cortical brain structure as assessed with structural T2-weighted magnetic resonance imaging. These re...
Neuropathological changes associated with Alzheimer's disease (AD) such as amyloidplaques, cerebral ...
Alzheimer disease (AD) is characterized by a loss of cognitive function caused by the dysfunction an...
Many Alzheimer’s disease (AD) patients suffer from altered cerebral blood flow and damaged cerebral ...
There is growing evidence for the vascular contribution to cognitive impairment and dementia in Alzh...
Several studies have shown decreased cerebral blood flow (CBF) in Alzheimer's disease (AD). However,...
Mixed pathology, with both Alzheimer’s disease and vascular abnormalities, is the most common cause ...
Introduction Mild cerebral hypoperfusion events are relevant in aged individuals. It has been report...
Background and Purpose�Chronic hypoperfusion in the mouse brain has been suggested to mimic aspect...
Alzheimer's disease is the most common neurodegenerative disease, and many patients also present wit...
Vascular cognitive impairment (VCI) encompasses all causes of cerebrovascular disease that lead to c...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Pathology, 2010.Th...
While prevailing evidence supports that the amyloid cascade hypothesis is a key component of Alzheim...
Cerebral blood flow (CBF) reductions in Alzheimer’s disease patients and related mouse models have b...
Alzheimer disease (AD) is marked by profound neurodegeneration, neuroinflammation, and cognitive dec...
Alzheimer's disease (AD) is the leading cause of cognitive impairment and dementia in elderly indivi...
Neuropathological changes associated with Alzheimer's disease (AD) such as amyloidplaques, cerebral ...
Alzheimer disease (AD) is characterized by a loss of cognitive function caused by the dysfunction an...
Many Alzheimer’s disease (AD) patients suffer from altered cerebral blood flow and damaged cerebral ...
There is growing evidence for the vascular contribution to cognitive impairment and dementia in Alzh...
Several studies have shown decreased cerebral blood flow (CBF) in Alzheimer's disease (AD). However,...
Mixed pathology, with both Alzheimer’s disease and vascular abnormalities, is the most common cause ...
Introduction Mild cerebral hypoperfusion events are relevant in aged individuals. It has been report...
Background and Purpose�Chronic hypoperfusion in the mouse brain has been suggested to mimic aspect...
Alzheimer's disease is the most common neurodegenerative disease, and many patients also present wit...
Vascular cognitive impairment (VCI) encompasses all causes of cerebrovascular disease that lead to c...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Pathology, 2010.Th...
While prevailing evidence supports that the amyloid cascade hypothesis is a key component of Alzheim...
Cerebral blood flow (CBF) reductions in Alzheimer’s disease patients and related mouse models have b...
Alzheimer disease (AD) is marked by profound neurodegeneration, neuroinflammation, and cognitive dec...
Alzheimer's disease (AD) is the leading cause of cognitive impairment and dementia in elderly indivi...
Neuropathological changes associated with Alzheimer's disease (AD) such as amyloidplaques, cerebral ...
Alzheimer disease (AD) is characterized by a loss of cognitive function caused by the dysfunction an...
Many Alzheimer’s disease (AD) patients suffer from altered cerebral blood flow and damaged cerebral ...